CORCEPT THERAPEUTICS, INC. v. HIKMA PHARMACEUTICALS USA INC. > Summary
Court Case Number 2:21-cv-05034
Filing Date Mar 12, 2021
Termination Date Dec 9, 2022
Court New Jersey District Court
Status Judgment - Judgment on Consent
JudgesEvelyn Padin, Leda D. Wettre
Plaintiff
Defendant
Plaintiff Attorneys
8Corcept Therapeutics
Attorney Name: William C. Baton
Saul Ewing LLP
Corcept Therapeutics
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Corcept Therapeutics
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Corcept Therapeutics
Attorney Name: Nicholas Anthony Locastro
Quinn Emanuel Urquhart & Sullivan
Corcept Therapeutics
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan
Corcept Therapeutics
Attorney Name: Daniel C. Wiesner
Quinn Emanuel Urquhart & Sullivan
Corcept Therapeutics
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Corcept Therapeutics
Attorney Name: John P. Galanek
Quinn Emanuel Urquhart & Sullivan
Defendant Attorneys
4Hikma Pharmaceuticals PLC
Attorney Name: James Richter
Midlige Richter
Hikma Pharmaceuticals PLC
Attorney Name: Sharon Lin
Winston & Strawn
Hikma Pharmaceuticals PLC
Attorney Name: Jovial Wong
Winston & Strawn
Hikma Pharmaceuticals PLC
Attorney Name: Charles B. Klein
Winston & Strawn
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10842800 | Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | Nov 24, 2020 |
| 10842801 | Optimizing mifepristone absorption | Nov 24, 2020 |
| 10500216 | Optimizing mifepristone absorption | Dec 10, 2019 |
| 10195214 | Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | Feb 5, 2019 |
